2024-11-25 03:41:27
Ascentage Pharma Announces Approval for the Phase Ib/II Clinical Study of MDM2-p53 Inhibitor APG-115 in Combination with Immunotherapy for the Treatment of Patients with Advanced Liposarcoma or other Advanced Solid Tumors in China
Corporate/ 2023-07-23
Ascentage Pharma Announces Approval for ...

SUZHOU,China and ROCKVILLE,Md.,Oct. 27,2020-- Ascentage Pharma (6855.HK),a globally focused,clinical-stage biotechnology company engaged in ...

VeChain, Renji Hospital and DNV GL Held Strategic Partnership Signing Ceremony To Launch World's First Blockchain Intelligent Tumor Treatment Center
Health/ 2023-07-22
VeChain, Renji Hospital and DNV GL Held ...

SHANGHAI,Oct. 27,2020--In partnership with VeChain and DNV GL,Renji Hospital,a top-ranked hospital in China affiliated with the Shanghai Jia...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release